Cancer doesn’t stop.

Genomic and Evolutionary Basis for Radiotherapy Response in Cervical Cancer

Roberto Vargas, MD

Decreasing chemotherapy induced distress using virtual reality in patients with Cancer

Zeina Nahleh, MD, FACP

Molecular mediators of disparate outcomes in African American patients with lung cancer

Daniel McGrail, PhD

Low intensity shockwave therapy as a non-invasive treatment for erectile dysfunction and pelvic pain in prostate cancer survivors

Petar Bajic, MD

Development of an anti-cancer stem cell therapy for glioblastoma by targeting the epigenetic state via WDR5

Justin Lathia, PhD

Cell Therapy for Triple Negative Breast Cancer Utilizing Reprogrammed T Lympthocytes

Marcela Diaz-Montero, PhD

Enabling Quantum Evolutionary Control in Cancer to Promote Drug Sensitivity

Jacob Scott, MD, DPhil

Elucidating the Metabolic Impact of Isocaloric, Controlled, Mediterranean-Type Diets in Treatment-Naive Men with Prostate Cancer on Active Surveillance (DINE study)

Nima Sharifi, MD

Epigenetic dysregulation of DNAJB6 isoform expression contributes to breast cancer invasion and metastasis

Angela Ting, PhD

3D HoloFusion for Percutaneous Multiprobe Ablation of Tumors

Charles Martin III, MD

Hypoxia-Regulated IncRNA in Glioblastoma Progression

Jennifer Yu, MD, PhD

Tissue Perfusion and Complications in Soft Tissue Sarcoma Surgery

Nathan Mesko, MD

Fertility Potential Preservation in Boys Facing Infertility-Causing Diseases or Treatment Regimens with Testicular Tissue Freezing

Sarah Vij, MD

Oligoadenylate Synthetases, a Novel Therapeutic Target in Myeloid Neoplasms

Babal Jha, PhD

Myeloid Neoplasms as a Global Spliceopathy. Implications for Molecular and Immune Pathogenesis

Richard Padgett, PhD

SMC2 Regulation of Chromosomal Instability in Triple Negative Breast Cancer

Ruth Keri, PhD

Metabolic and Epigenetic Effects of Mitochondrial Transfer in Glioblastoma

Justin Lathia, PhD